SCHEMBL1381632

SCHEMBL1381632

O=C(NCCCC1CC1)c1ccc(N2CCN(C(=O)c3cc(Cl)ccc3C(F)(F)F)CC2)nn1

nearest known ligand 0.90

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCD O00767 17/20 0.90
DCTPP1 Q9H773 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1380172 0.95 SCD (1.00) SCDDCTPP1
SCHEMBL1377027 0.92 SCD (0.93) SCDDCTPP1
SCHEMBL1377534 0.91 SCD (0.90) SCDDCTPP1
SCHEMBL1377337 0.88 SCD (0.79) SCDDCTPP1
SCHEMBL1377032 0.88 SCD (1.00) SCDDCTPP1
SCHEMBL2462958 0.86 SCD (0.68) SCD
SCHEMBL1380568 0.86 SCD (0.90) SCDDCTPP1
SCHEMBL1599828 0.85 SCD (0.84) SCDDCTPP1
SCHEMBL29438734 0.85 SCD (1.00) SCDDCTPP1
SCHEMBL936814 0.85 SCD (1.00) SCDDCTPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4808616-B2 2011-11-02 JP claimed
EP-1648874-B1 PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC (CA) 2011-10-05 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP claimed
EP-1846035-B1 COMBINATION THERAPY XENON PHARMACEUTICALS INC (CA) 2011-09-21 EP disclosed
US-7919484-B2 Combination therapy XENON PHARMACEUTICALS INC. (CA) 2011-04-05 US disclosed